Kursussøgning, efter- og videreuddannelse – Københavns Universitet

Videresend til en ven Resize Print Bookmark and Share

Kursussøgning, efter- og videreuddannelse

Safety of Medicines - from Non-clinical Development to Pharmacovigilance

Practical information
Study year 2016/2017
Time
Spring
Price

Prices vary according to type of enrolment and nationality. For details please visit: 

EU/EEA citizens

non-EU/EEA citizens

Programme level Part Time Master
ECTS 5 ECTS
Course responsible
  • Christine Erikstrup Hallgreen (19-676c766d77786d7269326c6570706b766969724477797268326f7932686f)
  • Department of Pharmacy
Course number: SMRMIF005U

Course content

The content of this course covers the regulatory issues concerning non-clinical development up to post marketing pharmacovigilance, with emphasis on regulatory issues concerning clinical development and pharmacovigilance.

The main purposes of the course is for the participant to acquire

1) An understanding of why non-clinical safety studies are conducted  including an understanding of methods for assessing safety in vitro and in vivo (animals),

2) To develop an understanding of and be able to analyze and apply the principles of safety monitoring in clinical phase I, II and III studies. These include in vivo pharmacology studies (e.g. temp, BP, ECG), PK/PD effects, and observations of ADR.

3) Awareness of the necessary pre-authorisation tasks concerning preparation of clinical study protocols pharmavigilance studies (phase IV), execution of clinical studies, preparation of periodic safety reports (PSUR/DSUR), along with other risk management activities after marketing.

After completion the student will be able to account for, scientifically discuss, advise on and evaluate the role of non-clinical safety, clinical and epidemiological scientific safety assessments as the basis for the continuing safety assessment of medicines.

Learning outcome

Knowledge

  • Define what non-clinical safety and clinical development and documentation is needed in order to fulfill regulatory requirements.
  • Explain the principles and management of pharmacovigilance and post-marketing risk assessment.
  • Identify the timing and requirement of non-clinical safety studies for both small molecules and biopharmaceuticals.

 

Skill

  • Discuss and evaluate non-clinical safety requirement for specific types of medicines for both small molecules and biopharmaceuticals.
  • Discuss and evaluate requirements for clinical and post-marketing safety assessments.
  • Evaluate efficacy and safety data obtained from non-clinical safety studies, clinical studies and post-marketing risk assessment.
  • Apply and evaluate requirements for post marketing pharmacovigilance.

 

Competencies

  • Plan and make decisions with regard to non-clinical development and documentation.
  • Review and assess global safety data at all levels of the drug development
  • Integrate all safety aspects when assessing drug candidates for selection and for selection of Marked Authorisation approval.
  • Take responsibility for continuous risk-benefit and pharmacovigilance

Recommended prerequisites

Applicants must meet the following criteria:
• A relevant bachelor degree or equivalent
• A minimum of 2 years of relevant job experience
• Proficiency in English

It would be an advantage to have passed the course ‘Clinical Development – Efficacy of medicines’ or equivalent course.

Sign up

Apply here

Education

Master of Medicines Regulatory Affairs (MRA)

Studyboard

Study Board for Part-time Master’s Programmes of Pharmaceutical Sciences

Course type

Part time Master and Diploma courses

Teacher

Harrie Boonen, SUND, KU
Ebba Holme Hansen, SUND, KU
Ole Bjerrum, SUND, KU
Helle Wallach Kildemoes, SUND, KU
Lise Tarnow, AU

Duration

3 + 2 days

Schedulegroup

Offered once a year: expected may
---- SKEMA LINK ----

Teaching and learning methods

Preparation (75 hours)
Lectures (35 hours)
Practical exercises (25 hours)

Capacity

24

Language

English

Literature

The syllabus comprises relevant EMA guidelines, EC directives, and a selection of books, book chapters, scientific papers and review papers, For example:

Text book (e.g. Talbot and Aronson, Stephens' Detection and Evaluation of Adverse Drug Reaction, Princples and Practice, Wiley & Sons 2012) 

A complete list of reading material will be distributed electronically before the course.

Workload

Category Hours
Preparation 75
Lectures 35
Theory exercises 25
Exam 3
English 138

Exam (SMRMIF005E)

Type of assessment

Written examination, 3 hours
Define an action plan on the basis of a case study (40%)
Short descriptive questions (60%)

Marking scale

7-point grading scale

Criteria for exam assessment

The exam is based on the combined evaluations of case study and questions.

To achieve the grade 12 the student should be able to:

Knowledge:

  • Explane Regulatory requirements for non-clinical safety and clinical development
  • Understand the principles and management of pharmacovigilance and post-marketing risk assessment.
  • Describe the requirement of non-clinical safety studies for both small drug molecules and biopharmaceuticals.

 

Skills:

  • Discuss and evaluate non-clinical safety requirement for specific types of medicines for both small molecules and biopharmaceuticals.
  • Discuss and evaluate requirements for clinical and post-marketing safety assessments.
  • Evaluate efficacy and safety data obtained from non-clinical safety studies, clinical studies and post-marketing risk assessment.
  • Apply and evaluate requirements for post marketing pharmacovigilance.

 

Competencies:

  • Plan and make decisions with regard to non-clinical development and documentation.
  • Review and assess global safety data at all levels of the drug development
  • Integrate all safety aspects when assessing drug candidates for selection and for selection of Marked Authorisation approval.
  • Take responsibility for continuous risk-benefit and pharmacovigilance

 

 

Censorship form

External censorship
Mere information om kurset
Er du BA- eller KA-studerende?
Er du bachelor- eller kandidat-studerende, så find dette kursus i kursusbasen for studerende:

Kursusinformation for indskrevne studerende